Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

Ruthee-lu Bayer is a Transplant Surgeon in Lake Success, New York. Dr. Bayer is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Sebastian Mayer is a Hematologist Oncology specialist and a Transplant Surgeon in New York, New York. Dr. Mayer is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Colonoscopy.

Ellin Berman is a Hematologist and an Oncologist in New York, New York. Dr. Berman is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant.

Virginia Klimek is an Oncologist in New York, New York. Dr. Klimek is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Chronic Myelomonocytic Leukemia (CMML), and Bone Marrow Aspiration.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

Bradley Goldberg, MD, is an attending physician based at the Monter Cancer Center where he specializes in treating patients with both benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Goldberg maintains an active practice where he focuses on compassionate, personalized, and evidence-based multi-disciplinary care. He is part of the team rotating through the inpatient malignant hematology service at North Shore University Hospital (located on 7 Monti). Dr. Goldberg earned his medical degree at SUNY Downstate College of Medicine. He completed his internal medicine residency and his medical oncology and hematology fellowship at the Northwell Health program located at North Shore University Hospital and Long Island Jewish Medical Center. He is currently an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.

Douglas Gladstone is a Transplant Surgeon in Lake Success, New York. Dr. Gladstone is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.

Jaime Londono is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Londono is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Myelodysplastic Syndrome (MDS), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

David Chitty, DO, MSc is an Attending physician at the Monter Cancer Center where he specializes in malignant hematology with a particular clinical interest in acute leukemias. Board certified in Internal Medicine and Medical Oncology, Dr. Chitty maintains an active practice where he focuses on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Chitty is a graduate of the Northwell Health Medical Oncology Translational Research Fellowship program. Prior to his Hematology/Oncology Fellowship, Dr. Chitty completed a residency in Internal Medicine at Maimonides Medical Center in Brooklyn, NY. A graduate of Nova Southeastern University School of Osteopathic Medicine, Dr. Chitty also earned a Master s in Science degree at the University of Ottawa, Ottawa, Canada in Cellular and Molecular Medicine. His work and research in the fields of medicine and oncology have been published in various peer-reviewed journals.Currently, his primary research interest is in the development and implementation of novel measurable residual disease assays. This work will allow clinicians to better implement targeted therapies into clinical practice for patients with resistant or residual disease following initial treatment. In addition, Dr. Chitty was instrumental in COVID-19 related research and continues to help push forward our understanding of COVID-19 disease in patients with cancer. Dr. Chitty is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Tissue Biopsy.

Wayne Tam is a Pathologist and a Medical Genetics provider in New Hyde Park, New York. Dr. Tam is rated as an Advanced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Childhood Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, Prolymphocytic Leukemia, and Chronic Myelogenous Leukemia (CML).

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as a Distinguished provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Judith Paula Brody, MD, is a Board-certified hematopathologist, Professor in Anatomic and Clinical Pathology, and past Senior Director of the Division of Hematopathology in the Department of Pathology and Laboratory at NSLIJ, a member of the department since 1986. With expertise in both anatomic and clinical pathology, Dr. Brody specializes in the diagnosis of hematologic disorders from tissue samples like bone marrow. She also oversees one of the laboratories responsible for testing related to hematologic disorders. She completed her MD degree at Northwestern University Feinberg School of Medicine and pursued her residencies at the University of Virginia in Anatomic/Clinical Pathology, and at the New England Deaconess Hospital in Boston, and was a member of the hematopathology department at the University of Pittsburgh Medical Center prior to NSLIJ position. It is important to note that Dr. Brody does not see patients in a clinical capacity and kindly requests not to be contacted for appointments as a clinical hematologist. Dr. Brody is rated as an Experienced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are Leukocytosis, Non-Hodgkin Lymphoma, Adult T-Cell Leukemia, and Acute Myeloid Leukemia (AML).

Xinmin Zhang is a Pathologist in Manhasset, New York. Dr. Zhang has been practicing medicine for over 37 years and is rated as an Experienced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Acute Myeloid Leukemia (AML).

Patrick Chang is a primary care provider, practicing in Internal Medicine in Great Neck, New York. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Sitosterolemia, High Cholesterol, Chronic Cough, and Anemia.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration.

Maria Jacqueline Nieto,MD,MSc is an Assistant Professor of Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell where she specializes in treating patients with benign and malignant hematological conditions.Dr Nieto is board certified in Internal Medicine and Medical Oncology. Dr Nieto's clinical focus is on myelodysplastic syndromes, myeloproliferative disorders, and lymphomas. She is particularly interested in the care of the elderly with hematological malignancies, evaluating treatment disparities in cancer care, and optimizing cancer and palliative care at the end of life. She is co-investigator on multiple clinical trials focused on the treatment of patients with hematological malignancies. Dr Nieto has a Master of Science degree in Clinical Research from New York University.Dr Nieto is an active member in the American Society of Clinical Oncology and the American Society of Hematology and is fluent in Spanish. Dr. Nieto is rated as an Experienced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, Bone Marrow Aspiration, and Tissue Biopsy.

An internationally known leader in hematology, A. Samer Al-Homsi, MD, MBA, is system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute, where he also serves as director of faculty and academic affairs in medical oncology.In his position, Dr. Al-Homsi treats patients in need of blood and marrow transplantation for blood cancers and other blood conditions. Dr. Al-Homsi attended medical school at Damascus University Faculty of Medicine, did his residency at Advocate Christ Medical Center in Illinois, and completed a fellowship at UMass Chan Medical School in Worcester, MA. He also received training and practiced in France. He came to Northwell from the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, where he was executive director of transplantation and cellular therapy. His research efforts throughout his career have focused on innovations that lead to better patient care in blood and marrow transplantation.The poet Kahlil Gibran wrote that work is love made visible, and I believe medicine is love made visible, says Dr. Al-Homsi. Every patient has unique needs, based not just on their specific condition, but also on their cultural background, family situation, and the impact of their disease. We're fortunate at Northwell to have care delivered by a large team that's there to address all those aspects.Dr. Al-Homsi is looking forward to advancing more clinical research at Northwell's Feinstein Institutes for Medical Research and at Cold Spring Harbor Laboratory. That will likely facilitate the development of more therapies that can treat patients, he says, and in a way that's safer and more effective.Dr. Al-Homsi doesn't just focus on the physical effects of conditions like leukemia, lymphoma, and multiple myeloma with decades of patient care, he also knows the tremendous value of a deeper conversation about how cancer is affecting patients mental health and everyday function. His priority is to learn about the patient first and the disease second.That perspective on patient advocacy and approaching each interaction with compassion and love is the same now as it was when he first entered medical school, he recalls. I wanted my life to matter, and to make a difference, he says. I'm not trying to change the world, but I can change patients' lives. I can change their world, and that's incredibly rewarding and meaningful. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Childhood Acute Myeloid Leukemia. His top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Adult T-Cell Leukemia, Chronic T-Cell Leukemia (CTCL), and Bone Marrow Transplant.